Tampere University is a Finnish university that was established on 1 January, 2019 as a merger between the University of Tampere and Tampere University of Technology. The new university is also the major shareholder of Tampere University of Applied Sciences.

During the past decade, University of Tampere conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Tampere" #1 sponsor was "Tampere University" with 3 trials, followed by "Tampere University Hospital" with 2 trials sponsored, "VBI Vaccines Inc." with 2 trials sponsored, "Helsinki University Central Hospital" with 1 trials sponsored and "JAMK University Of Applied Sciences" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Tampere" #1 collaborator was "Tampere University" with 3 trials as a collaborator, "Academy of Finland" with 1 trials as a collaborator, "Central Finland Hospital District" with 1 trials as a collaborator, "Clinical Research Institute HUCH Ltd, Finland" with 1 trials as a collaborator and "Fimlab Laboratories, Finland" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "University of Tampere" are "Hepatitis B Vaccines" (2 trials), "Prostate Cancer" (2 trials), "Celiac Disease" (1 trials), "Colon Cancer" (1 trials) and "Depression" (1 trials). Many other conditions were trialed in "University of Tampere" in a lesser frequency.

Most popular intervention types in "University of Tampere" are "Biological" (3 trials), "Procedure" (3 trials), "Dietary Supplement" (2 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Hepatitis B Vaccination" (2 trials), "11C-Metomidate Positron Emission Tomography" (1 trials), "CAIV-T" (1 trials), "Curative operation" (1 trials) and "Flow with Nature" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Tampere" are 10 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Tampere". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in University of Tampere, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Tampere, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

University of Tampere has several departments that took part in Clinical trials: "Tampere University Hospital; Dept of Oncology" - 14 trials, "University of Tampere Medical School" - 6 trials, "Tampere University Hospital; Dept Of Urology" - 2 trials